allogeneic mait cell therapy
Generic: Mucosal-associated invariant T (MAIT) cells
allogeneic mait cell therapy: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Pluri Inc. (PLUR) | Preclinical |
Get deeper analysis on allogeneic mait cell therapy
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis